10/27/2022
South Korea as a Global Vaccine Hub
In a submission for the 2022 KEI Academic Paper Series, Coauhors Tom Byrne, Claire Callahan, Irene Kyoung, and Salomé Da Silva Duarte Lepez explore South Korea’s aspiration to achieve the status of global vaccine hub as a national strategic policy priority. The paper first outlines the characteristics of a global vaccine hub and a WHO biotechnology hub, touches on collaborative vaccine efforts in Asia, and then discusses the institutional structure of South Korea’s global vaccine hub and the country’s Covid-19 partnerships. The paper provides an overview of global vaccines, including Covid-19 vaccine production, showing where South Korea fits into that ecosystem, and summarizes global vaccine diplomacy efforts. The paper notes the laudable achievements of Operation Warp Speed in the U.S. (and in the presentation, the Vaccine Task Force in the U.K.) in rapidly producing safe and effective vaccines early in the pandemic, although vaccine nationalism inevitably prevailed as global demand exceeded supply. The paper also notes the shortcomings of national and bilateral vaccine diplomacy, as well as multilateral mechanisms, in providing vaccine access and ensuring equity. It concludes that South Korea’s demonstrated capabilities to rise as a global vaccine development, manufacturing, and training hub will help bolster global public health capacities in the future.
Click here to read.
To watch the paper presentation program, click here
